Journey II XR
Device Recon Knees
PDI 00885556242643
General payments
$2,108,927
Research payments
$446,881
Through program year 2025, $2,108,927 in general payments and $446,881 in research payments were reported against Journey II XR (Recon Knees).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $646,685 | 72 |
| 2025 | Research | $50,285 | 21 |
| 2024 | General | $827,137 | 55 |
| 2024 | Research | $24,049 | 11 |
| 2023 | General | $30,481 | 57 |
| 2023 | Research | $156,671 | 26 |
| 2022 | General | $207,877 | 218 |
| 2022 | Research | $86,908 | 44 |
| 2021 | General | $396,747 | 288 |
| 2021 | Research | $128,968 | 51 |
Breakdown
The top 5 of 39 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
690 general · 153 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.